Literature DB >> 12975395

Acquired combined immunodeficiency associated with protein losing enteropathy complicating Fontan operation.

S Chakrabarti1, B R Keeton, A P Salmon, J J Vettukattil.   

Abstract

It is vitally important that the immunological aspect of protein losing enteropathy following Fontan procedures is highlighted, in order to decrease significant morbidity and mortality

Entities:  

Mesh:

Year:  2003        PMID: 12975395      PMCID: PMC1767867          DOI: 10.1136/heart.89.10.1130

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  Circumscribed intestinal protein loss with deficiency in CD4+ lymphocytes after the Fontan procedure.

Authors:  A Koch; M Hofbeck; H Feistel; G Buheitel; H Singer
Journal:  Eur J Pediatr       Date:  1999-10       Impact factor: 3.183

2.  Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure.

Authors:  A J Powell; K Gauvreau; K J Jenkins; E D Blume; J E Mayer; J E Lock
Journal:  Am J Cardiol       Date:  2001-11-15       Impact factor: 2.778

3.  Five- to fifteen-year follow-up after Fontan operation.

Authors:  D J Driscoll; K P Offord; R H Feldt; H V Schaff; F J Puga; G K Danielson
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

4.  Protein-losing enteropathy after the Fontan operation: an international multicenter study. PLE study group.

Authors:  L Mertens; D J Hagler; U Sauer; J Somerville; M Gewillig
Journal:  J Thorac Cardiovasc Surg       Date:  1998-05       Impact factor: 5.209

5.  Excessive loss of plasma protein into the gastrointestinal tract associated with primary myocardial disease.

Authors:  L S Valberg; W E Corbett; J R McCorriston; J O Parker
Journal:  Am J Med       Date:  1965-10       Impact factor: 4.965

6.  Protein-losing enteropathy complicating the Mustard procedure.

Authors:  S K Krueger; D W Burney; R M Ferlic
Journal:  Surgery       Date:  1977-03       Impact factor: 3.982

7.  Immunodeficiency and the gastrointestinal tract.

Authors:  W F Doe
Journal:  Clin Gastroenterol       Date:  1983-09

8.  Administration of intravenous immunoglobulin in two children with hypogammaglobulinaemia due to protein losing enteropathy.

Authors:  C De Giacomo; G Maggiore; M S Scotta; A G Ugazio
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

Review 9.  Strategies to treat protein-losing enteropathy.

Authors:  Jack Rychik; Thomas L Spray
Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu       Date:  2002

10.  Cellular immunodeficiency in protein-losing enteropathy. Predominant reduction of CD3+ and CD4+ lymphocytes.

Authors:  C Müller; H Wolf; J Göttlicher; C C Zielinski; M M Eibl
Journal:  Dig Dis Sci       Date:  1991-01       Impact factor: 3.199

View more
  7 in total

1.  Successful combined intravenous and subcutaneous immunoglobulin treatment for intractable protein-losing enteropathy in a patient long after Fontan-type operation.

Authors:  Yoshiyuki Kagiyama; Shintaro Kishimoto; Hironaga Yoshimoto; Yoshiyuki Kudo; Kenji Gotoh; Kenji Suda
Journal:  J Cardiol Cases       Date:  2017-10-16

Review 2.  Current treatment and prognosis in children with functionally univentricular hearts.

Authors:  R Kaulitz; M Hofbeck
Journal:  Arch Dis Child       Date:  2005-07       Impact factor: 3.791

3.  Protein-losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable Immunodeficiency.

Authors:  Sébastien Sanges; Nicolas Germain; Stéphane Vignes; David Séguy; Sarah Stabler; Nicolas Etienne; Louis Terriou; David Launay; Éric Hachulla; Damien Huglo; Sylvain Dubucquoi; Myriam Labalette; Guillaume Lefèvre
Journal:  J Clin Immunol       Date:  2022-06-23       Impact factor: 8.542

Review 4.  Medical management of the failing Fontan.

Authors:  N S Ghanayem; S Berger; J S Tweddell
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

5.  Low immunoglobulin M memory B-cell percentage in patients with heterotaxy syndrome correlates with the risk of severe bacterial infection.

Authors:  Shuenn-Nan Chiu; Pei-Lan Shao; Jou-Kou Wang; Hui-Wen Hsu; Ming-Tai Lin; Luan-Yin Chang; Chun-Yi Lu; Ping-Ing Lee; Li-Min Huang; Mei-Hwan Wu
Journal:  Pediatr Res       Date:  2015-11-02       Impact factor: 3.756

Review 6.  Mechanical Circulatory Support for Single Ventricle Failure.

Authors:  Massimo Griselli; Raina Sinha; Subin Jang; Gianluigi Perri; Iki Adachi
Journal:  Front Cardiovasc Med       Date:  2018-08-28

Review 7.  The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.

Authors:  Smita Y Patel; Javier Carbone; Stephen Jolles
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.